| Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Outline of Final Research Achievements |
Administration of GLP-1 receptor agonists has the effect of reducing the risk of cardiovascular complications. However, there are few reports on the protective effect of GLP-1 on myocardial stunning.
In this study, we investigated the effect of pre-ischemic or post-reperfusion administration of liraglutide on recovery from myocardial ischemia-reperfusion injury in a porcine myocardial stunning model. Administration prior to ischemia and after reperfusion has been shown to improve recovery from myocardial stunning.
|
